Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

NCT02396043 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Lymphoblastic

Interventions

DRUG: induction phase1
DRUG: induction phase2
DRUG: protocol M
DRUG: maintenance therapy
DRUG: reinduction phase1
DRUG: reinduction phase2
DRUG: Intrathecal (IT)

Sponsor

Sun Yat-sen University